¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº Cancer Institute

Home
Menu

EEC meeting, SIOPE, 23-24 May 2019, Prague

The next EEC meeting will take place at SIOPE during the European Bone Sarcoma Networking Meeting (EBSNM). EEC sessions will be held on the afternoon of Thursday 23 May 2019.

The full programme and information on the venue and accommodation can be found on the SIOP Europe website where you can also find out about the social events.

Agenda (pdf)

Thursday 23 May 2019

13:00-14:30Lunch
14:30-14:40Introduction – Stefan Bielack and Jeremy Whelan
ÌýSession 1 Ewing sarcoma
14:40-14:50Achievements of European collaboration in Ewing sarcoma – Jeremy Whelan
14:50-15:05EUROEWING 2012 – Keith Wheatley
15:05-15:20EWING 2008 – Uta Dirksen
15:20-15:35Progress in recurrent and refractory disease – Martin McCabe
15:35-15:50Introducing and testing new agents – Claudia Valverde
15:50-16:00Discussion
16:00-16:30Coffee break
ÌýSession 2 Current dilemmas
16:30-16:50When is radiotherapy indicated for ES? - Beate Timmerman
16:50-17:20Does computer navigation improve patient outcomes for pelvic and other resections? What are the implications for future care? - Michael Parry
17:20-17:40How could ERNs affect the European bone sarcoma community - Ruth Ladenstein
17:40-18:00Lessons from the COG Soft Tissue Sarcoma Committee regarding opportunities for international collaboration - Doug Hawkins
ÌýDiscussion
20:00

Networking evening

ArrostoÌýÌýÌý


Friday 24 May 2019
08:30-10:30 ÌýÌý ÌýSession 3 Osteosarcoma
08:30-08:45 ÌýÌý ÌýEURAMOS-1: Past, present and future achievements of European collaboration in Osteosarcoma – Stefan Bielack
08:45-09:00 ÌýÌý ÌýWhat can a national programme of trials for osteosarcoma achieve? Nathalie Gaspar
09:00-09:15 ÌýÌý ÌýBRCAness revisited - Michaela Nathrath
09:15-09:30 ÌýÌý ÌýMolecular evolution of osteosarcoma through time – Daniel Baumhoer
09:30-09:45 ÌýÌý ÌýTreatment options beyond 1st line in osteosarcoma (recurrent non-resectable tumours) - Emanuela Palmerini
09:45-10:00 ÌýÌý ÌýWhy would countries like to join existing infrastructure and how could they do this? - Anna Raciborska
10:00-10:15 ÌýÌý ÌýICONIC – a national cohort study – Sandra Strauss
10:15-10:30 ÌýÌý ÌýDiscussion
10:30-11:00 ÌýÌý ÌýCoffee break
11:00-13:00 ÌýÌý ÌýSession 4 More Dilemmas and Challenges
11:00-11:15 ÌýÌý ÌýTargeting Metastasis in Ewing Sarcoma with T Cell Receptor Based Immunotherapy – Stefan Burdach
11:15-11:30 ÌýÌý ÌýEwing sarcoma as a second malignancy - Katja Kauertz
11:30-11:45 ÌýÌý ÌýWhere are we with tumours carrying BCOR-CCNB3 and CIC–DUX4 fusions? -Ìý Enrique d’Alava
11:45-12:00 ÌýÌý ÌýWhat does the bone sarcoma community require of the ITCC and vice versa? – Nathalie Gaspar
12:00 -12:30 ÌýÌý ÌýLessons from the past 10 years of COG Bone Tumor Committee Trials and Tribulations and Thoughts about the Future of International Collaboration - Katie Janeway
12:30-13:00 ÌýÌý Ìý

What studies can we do?

Bielack, Whelan, Janeway to lead discussion
13:00-14:00 ÌýÌý ÌýLunch
14:00-16:00 ÌýÌý ÌýCLOSED MEETING Bone Tumour Data Harmonization (agenda (pdf))
16:00-16:30 ÌýÌý ÌýCoffee break
16:30-18:00 ÌýÌý ÌýCLOSED MEETING Bone Tumour Data Harmonization